Exane Derivatives’s iShares MSCI Singapore ETF EWS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-477
Closed -$10.9K 647
2017
Q1
$10.9K Sell
477
-11,456
-96% -$251K ﹤0.01% 349
2016
Q4
$238K Hold
11,933
0.05% 195
2016
Q3
$259K Sell
11,933
-429
-3% -$9.33K 0.04% 190
2016
Q2
$269K Buy
12,362
+10,320
+505% +$220K 0.04% 182
2016
Q1
$44.3K Buy
2,042
+2,038
+50,950% +$40.2K 0.01% 330
2015
Q4
$72 Sell
4
-52
-93% -$1.12K ﹤0.01% 462
2015
Q3
$1.13K Hold
56
﹤0.01% 425
2015
Q2
$1.4K Hold
56
﹤0.01% 430
2015
Q1
$1.42K Hold
56
﹤0.01% 436
2014
Q4
$1.45K Buy
+56
New +$1.48K ﹤0.01% 468

Other funds holding EWS

Exane Derivatives's EWS Position: Q2 2017 in Review

Exane Derivatives sold out of iShares MSCI Singapore ETF (EWS) in Q2 2017, closing a stake of 477 shares — an estimated $10.9K sold.

Exane Derivatives first reported a position in EWS in Q4 2014 and held it in 10 quarters. The position peaked at $269K in Q2 2016. 111 funds tracked by Wall St. Rank hold EWS as of Q2 2017.

  • Exane Derivatives reported no remaining iShares MSCI Singapore ETF position as of Q2 2017 after selling out during the quarter.
  • Exane Derivatives sold 477 iShares MSCI Singapore ETF shares in Q2 2017, an estimated $10.9K.
  • Exane Derivatives first reported a position in iShares MSCI Singapore ETF in Q4 2014 and held it in 10 quarters.
  • Exane Derivatives's iShares MSCI Singapore ETF position peaked at $269K in Q2 2016.
  • 111 funds tracked by Wall St. Rank held iShares MSCI Singapore ETF as of Q2 2017.

Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.